Dietary melatonin and its benefits on cardiovascular disease

Br J Pharmacol. 2026 Sep 25. doi: 10.1111/bph.70673. Online ahead of print.ABSTRACTCardiovascular disease remains the leading cause of mortality globally, with a disproportionate burden in low- and middle-income countries. Melatonin, a hormone primarily produced by the pineal gland, exhibits notable

K Karabo Tisane

Cardiac Implantable Electronic Devices Management in Older Adults ≥75 Years Old: From Underrepresentation in Clinical Trials to Overrepresentation in Contemporary Clinical Practice

Curr Cardiol Rev. 2026 Sep 21. doi: 10.2174/011573403X485322260904063323. Online ahead of print.ABSTRACTCardiac Implantable Electronic Devices (CIEDs), ranging from Permanent Pacemakers (PPMs) for bradycardia, Implantable Cardioverter-Defibrillators (ICDs), to Cardiac Resynchronization Therapy (CRT)

M Matthew F Yuyun

Variations in Single-Point Insulin Sensitivity Estimator Index and the Risk of Cardiovascular Disease in Individuals With Cardiovascular-Kidney-Metabolic Syndrome Stages 0 to 3: A National Longitudinal Cohort Study

J Am Heart Assoc. 2026 Sep 24:e051048. doi: 10.1161/JAHA.126.051048. Online ahead of print.ABSTRACTBACKGROUND: Prior studies have focused exclusively on baseline single-point insulin sensitivity estimator (SPISE) index levels, and the prognostic impact of longitudinal SPISE index trajectories on inc

Y Yumeng Shi

JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke Neurology

J Am Heart Assoc. 2026 Sep 24:e050497. doi: 10.1161/JAHA.126.050497. Online ahead of print.ABSTRACTRecent evidence suggests the JAK2V617F mutation may confer an elevated risk of ischemic stroke, likely mediated by systemic inflammation, abnormal cell activation, and endothelial dysfunction. The JAK2

M Marie H Kristiansen